SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-010321
Filing Date
2021-09-23
Accepted
2021-09-23 09:51:26
Documents
50
Period of Report
2021-09-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gtbp_8k.htm   iXBRL 8-K 19530
2 DR. JEFFREY MILLER PRESENTATION gtbp_ex991.htm EX-99.1 6882
3 GT BIOPHARMA, INC. CORPORATE PRESENTATION gtbp_ex992.htm EX-99.2 15443
4 IMAGE gtbp_ex991img1.jpg GRAPHIC 102918
5 IMAGE gtbp_ex991img10.jpg GRAPHIC 75003
6 IMAGE gtbp_ex991img2.jpg GRAPHIC 57806
7 IMAGE gtbp_ex991img3.jpg GRAPHIC 77642
8 IMAGE gtbp_ex991img4.jpg GRAPHIC 96473
9 IMAGE gtbp_ex991img5.jpg GRAPHIC 76357
10 IMAGE gtbp_ex991img6.jpg GRAPHIC 54383
11 IMAGE gtbp_ex991img7.jpg GRAPHIC 78120
12 IMAGE gtbp_ex991img8.jpg GRAPHIC 94773
13 IMAGE gtbp_ex991img9.jpg GRAPHIC 91686
14 IMAGE gtbp_ex992img1.jpg GRAPHIC 26914
15 IMAGE gtbp_ex992img10.jpg GRAPHIC 109194
16 IMAGE gtbp_ex992img11.jpg GRAPHIC 60897
17 IMAGE gtbp_ex992img12.jpg GRAPHIC 73841
18 IMAGE gtbp_ex992img13.jpg GRAPHIC 50267
19 IMAGE gtbp_ex992img14.jpg GRAPHIC 60121
20 IMAGE gtbp_ex992img15.jpg GRAPHIC 81345
21 IMAGE gtbp_ex992img16.jpg GRAPHIC 78921
22 IMAGE gtbp_ex992img17.jpg GRAPHIC 53315
23 IMAGE gtbp_ex992img18.jpg GRAPHIC 45496
24 IMAGE gtbp_ex992img19.jpg GRAPHIC 64470
25 IMAGE gtbp_ex992img2.jpg GRAPHIC 151953
26 IMAGE gtbp_ex992img20.jpg GRAPHIC 79141
27 IMAGE gtbp_ex992img21.jpg GRAPHIC 75028
28 IMAGE gtbp_ex992img22.jpg GRAPHIC 78826
29 IMAGE gtbp_ex992img23.jpg GRAPHIC 56162
30 IMAGE gtbp_ex992img24.jpg GRAPHIC 26967
31 IMAGE gtbp_ex992img3.jpg GRAPHIC 48110
32 IMAGE gtbp_ex992img4.jpg GRAPHIC 115744
33 IMAGE gtbp_ex992img5.jpg GRAPHIC 60022
34 IMAGE gtbp_ex992img6.jpg GRAPHIC 63579
35 IMAGE gtbp_ex992img7.jpg GRAPHIC 70060
36 IMAGE gtbp_ex992img8.jpg GRAPHIC 71328
37 IMAGE gtbp_ex992img9.jpg GRAPHIC 69418
  Complete submission text file 0001654954-21-010321.txt   3581759

Data Files

Seq Description Document Type Size
38 XBRL TAXONOMY EXTENSION SCHEMA gtpb-20210917.xsd EX-101.SCH 5595
39 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gtpb-20210917_cal.xml EX-101.CAL 890
40 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gtpb-20210917_def.xml EX-101.DEF 2097
41 XBRL TAXONOMY EXTENSION LABEL LINKBASE gtpb-20210917_lab.xml EX-101.LAB 14803
42 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gtpb-20210917_pre.xml EX-101.PRE 9411
43 EXTRACTED XBRL INSTANCE DOCUMENT gtbp_8k_htm.xml XML 3598
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40023 | Film No.: 211271284
SIC: 2834 Pharmaceutical Preparations